Literature DB >> 15289146

Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma.

Khalid F Tabbara1.   

Abstract

PURPOSE: To present a case of ligneous conjunctivitis where the recurrence of membranous conjunctivitis was prevented by subconjunctival and topical instillation of fresh frozen plasma.
DESIGN: Interventional case report.
METHODS: A case of ligneous conjunctivitis with multiple recurrences since the age of 3 years developed recurrent membranous conjunctivitis after transconjunctival levator recession. Blood plasminogen activity was determined. The membrane was excised, and the membrane reappeared 4 days later. The patient was treated with excision of the membrane and subconjunctival injection of fresh frozen plasma and topical fresh frozen plasma. Plasminogen activity of the fresh frozen plasma was normal.
RESULTS: Plasminogen blood functional activity was 52% (normal is 80%-120%). The patient had complete remission with no recurrences of membranous conjunctivitis after topical and subconjunctival fresh frozen plasma.
CONCLUSIONS: Prophylactic use of topical and subconjunctival fresh frozen plasma may help in the prevention of membranes in susceptible patients with plasminogen deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289146     DOI: 10.1016/j.ajo.2004.02.067

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement.

Authors:  M Teresa Rodríguez-Ares; Ihab Abdulkader; Ana Blanco; Rosario Touriño-Peralba; Clara Ruiz-Ponte; Ana Vega; José Cameselle-Teijeiro
Journal:  Virchows Arch       Date:  2007-08-15       Impact factor: 4.064

2.  Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases.

Authors:  Verónica Pons; Pável Olivera; Roberto García-Consuegra; Laura López-Andreoni; Nieves Martín-Begué; Angel García; Juliana Hidalgo; Francesc Bosch; Amparo Santamaría
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

3.  Induction of bilateral ligneous conjunctivitis with the use of a prosthetic eye.

Authors:  Bülent Yazıcı; Meral Yıldız; Tayfun Irfan
Journal:  Int Ophthalmol       Date:  2010-06-04       Impact factor: 2.031

4.  Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency.

Authors:  Amy D Shapiro; Charles Nakar; Joseph M Parker; Gary R Albert; John E Moran; Karen Thibaudeau; Neelam Thukral; Brandon M Hardesty; Pierre Laurin; Per Morten Sandset
Journal:  Blood       Date:  2018-01-10       Impact factor: 22.113

5.  Management of ligneous conjunctivitis in a child with plasminogen deficiency.

Authors:  Helen Pergantou; Dimitra Likaki; Maria Fotopoulou; Olga Katsarou; Panagiota Xafaki; Helen Platokouki
Journal:  Eur J Pediatr       Date:  2011-05-31       Impact factor: 3.183

Review 6.  Plasminogen deficiency.

Authors:  Tiraje Celkan
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 7.  An international registry of patients with plasminogen deficiency (HISTORY).

Authors:  Amy D Shapiro; Marzia Menegatti; Roberta Palla; Marco Boscarino; Christopher Roberson; Paolo Lanzi; Joel Bowen; Charles Nakar; Isaac A Janson; Flora Peyvandi
Journal:  Haematologica       Date:  2020-01-30       Impact factor: 9.941

8.  Recurrent ligneous conjunctivitis after cataract surgery in a 67-year-old male patient: a case report.

Authors:  Amine Maamri; Elena Zemova; Kayed Moslemani; Fidelis Flockerzi; Berthold Seitz
Journal:  BMC Ophthalmol       Date:  2022-03-05       Impact factor: 2.209

9.  Treatment of ligneous conjunctivitis with amniotic membrane transplantation and topical cyclosporine.

Authors:  Ozlem Yalcin Tok; Fatma Akbas Kocaoglu; Levent Tok; Ayse Burcu; Firdevs Ornek
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.